A Phase 3 interventional study of Ferrous sulphate tablets in Hip Fracture, sponsored by Peterborough and Stamford Hospitals NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2012-12-10.
Sponsored by Peterborough and Stamford Hospitals NHS Foundation Trust · Phase 3, Interventional, and Treatment
At present our current practice is to provide a course of oral iron therapy for those patients with a post-operative haemoglobin which is below normal, but not severe enough to require a blood transfusion. Such a practice is not without side effects from the iron tablets, namely ingestion, nausea, diarrhoea, constipation. There is little evidence in the literature to support the current practice of using iron, with only one small randomised trial suggesting such therapy is unnecessary. We propose to recruit 300 patients recovering from a hip fracture with a post-operative haemoglobin below 11g/l. For those patients willing to enter the study, half will be given oral iron therapy (ferrous sulphate 200mg twice daily) for one month. The haemoglobin will be checked when the patients attends the hip fracture clinic at 6 weeks after discharge.
1,733 studies on the registry are indexed under Anemia; 246 are open to participants now.
This study's enrollment of 300 is above the median of 94 across 1,291 interventional studies indexed under Anemia.
Browse Anemia studies →Peterborough and Stamford Hospitals NHS Foundation Trust is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
no iron given
iron given
Drug: Ferrous sulphate tablets
200mg twice daily for four weeks
6 week hemoglobin
Time frame: 6 weeks after surgery
Length of hospital stay side effects of therapy mortality
Time frame: one year
This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peterborough and Stamford Hospitals NHS Foundation Trust